Polyamine conjugates of meso-tritolylporphyrin and protoporphyrin IX: potential agents for photodynamic therapy of cancers

Bioorg Med Chem. 2006 Mar 1;14(5):1364-77. doi: 10.1016/j.bmc.2005.09.071. Epub 2005 Nov 2.

Abstract

An efficient five-step synthesis method was developed to obtain tritolylporphyrin and protoporphyrin IX polyamine conjugates. These compounds were composed of either one polyamine unit (spermidine or spermine) covalently tethered to monocarboxyphenyl tritolylporphyrin or two molecules of polyamines borne by protoporphyrin IX. In each compound, an aliphatic spacer arm is linked to the N(4) polyamine position. Photocytotoxicity of these new compounds was evaluated against K562 human chronic myelogenous leukemia cells and compared to Photofrin II; protoporphyrin IX polyamine conjugates exhibited much stronger photocytocicity than Photofrin II and were shown to readily induce necrosis in treated cells.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Dihematoporphyrin Ether / pharmacology
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Necrosis / chemically induced
  • Photochemotherapy*
  • Polyamines / chemistry*
  • Porphyrins / chemistry*
  • Porphyrins / pharmacology
  • Protoporphyrins / chemistry*
  • Protoporphyrins / pharmacology
  • Spectroscopy, Fourier Transform Infrared
  • Spermidine / chemistry
  • Spermidine / pharmacology
  • Spermine / chemistry
  • Spermine / pharmacology
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Polyamines
  • Porphyrins
  • Protoporphyrins
  • Spermine
  • Dihematoporphyrin Ether
  • protoporphyrin IX
  • Spermidine